{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:23:39Z","timestamp":1778678619216,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":874,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.bcp.2010.12.016","type":"journal-article","created":{"date-parts":[[2010,12,25]],"date-time":"2010-12-25T09:18:04Z","timestamp":1293268684000},"page":"736-742","source":"Crossref","is-referenced-by-count":33,"title":["Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B2 and M1 muscarinic acetylcholine receptors"],"prefix":"10.1016","volume":"81","author":[{"given":"K.L.P.","family":"Morais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.F.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lopes-Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.M.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lameu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.bcp.2010.12.016_bib0005","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/bi00815a005","article-title":"Isolation of bradykinin potentiating peptides from Bothrops jararaca venom","volume":"9","author":"Ferreira","year":"1970","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bcp.2010.12.016_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10409238409108720","article-title":"Angiontesin-converting enzyme inhibitions: biochemical properties and biological actions","volume":"16","author":"Ondetti","year":"1984","journal-title":"CRC Crit Rev Biochem"},{"key":"10.1016\/j.bcp.2010.12.016_bib0015","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0006-2952(71)90284-X","article-title":"Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro: an inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II","volume":"20","author":"Stewart","year":"1971","journal-title":"Biochem Pharmacol"},{"issue":"25","key":"10.1016\/j.bcp.2010.12.016_bib0020","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/bi00644a014","article-title":"Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids","volume":"16","author":"Cushman","year":"1977","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bcp.2010.12.016_bib0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/jm00136a001","article-title":"Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension","volume":"24","author":"Ondetti","year":"1981","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bcp.2010.12.016_bib0030","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1096\/fj.03-0093life","article-title":"The discovery of captopril","volume":"17","author":"Smith","year":"2003","journal-title":"FASEB J"},{"issue":"22","key":"10.1016\/j.bcp.2010.12.016_bib0035","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1021\/bi00798a004","article-title":"Angiotensins-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis","volume":"19","author":"Ondetti","year":"1971","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2010.12.016_bib0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.94.4.1189","article-title":"Cloning and sequence of a Bothrops jararaca cDNA encoding a precursor of seven bradykinin-potentiating peptides and a C-type natriuretic peptide","volume":"94","author":"Murayama","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.bcp.2010.12.016_bib0045","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.toxicon.2005.02.017","article-title":"The Bradykinin-potentiating peptides from venom gland and brain of Bothrops jararaca contain highly site specific inhibitors of the somatic angiotensin-converting enzyme","volume":"45","author":"Hayashi","year":"2005","journal-title":"Toxicon"},{"issue":"14","key":"10.1016\/j.bcp.2010.12.016_bib0050","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1016\/S0021-9258(18)31543-6","article-title":"The two homologous domains of human angiotensin I-converting enzyme are both catalytically active","volume":"266","author":"Wei","year":"1991","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bcp.2010.12.016_bib0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1357-2725(02)00309-6","article-title":"The angiotensin converting enzyme (ACE)","volume":"35","author":"Coates","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bcp.2010.12.016_bib0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/jpet.107.120873","article-title":"Do the cardiovascular effects of angiotensina-converting enzyme (ACE) I involve ACE-independent mechanisms? New insights from proline-rich peptides of Bothrops jararaca","volume":"322","author":"Ianzer","year":"2007","journal-title":"J Pharm Exp Ther"},{"issue":"284","key":"10.1016\/j.bcp.2010.12.016_bib0065","doi-asserted-by":"crossref","first-page":"20022","DOI":"10.1074\/jbc.M109.021089","article-title":"Argininosuccinate synthetase is a novel functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production","volume":"30","author":"Guerreiro","year":"2009","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.bcp.2010.12.016_bib0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cyto.a.20860","article-title":"The central nervous system as target for antihypertensive actions of a proline-rich peptide from Bothrops jararaca venom","volume":"77","author":"Lameu","year":"2010","journal-title":"Cytometry A"},{"key":"10.1016\/j.bcp.2010.12.016_bib0075","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1146\/annurev.ph.57.030195.004011","article-title":"Nitric oxide in the regulation of blood flow and arterial pressure","volume":"57","author":"Umans","year":"1995","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"10.1016\/j.bcp.2010.12.016_bib0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/07853899509002586","article-title":"Regulation and functional consequences of endothelial nitric oxide formation","volume":"27","author":"Busse","year":"1995","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.bcp.2010.12.016_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1081\/PRG-120017005","article-title":"Nitric oxide production by decidual endothelial cells is not reduced in preeclampsia","volume":"22","author":"Rowe","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.bcp.2010.12.016_bib0090","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1242\/jeb.00361","article-title":"The caveolar nitric oxide synthase\/arginine regeneration system for NO production in endothelial cells","volume":"206","author":"Solomonson","year":"2003","journal-title":"J Exp Biol"},{"issue":"2","key":"10.1016\/j.bcp.2010.12.016_bib0095","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1073\/pnas.87.2.682","article-title":"Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme","volume":"87","author":"Bredt","year":"1990","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.bcp.2010.12.016_bib0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.88.2.365","article-title":"Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase","volume":"88","author":"Schmidt","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.12.016_bib0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.niox.2007.07.001","article-title":"Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle","volume":"17","author":"Flam","year":"2007","journal-title":"Nitric Oxide"},{"issue":"7","key":"10.1016\/j.bcp.2010.12.016_bib0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.archoralbio.2008.01.016","article-title":"Cholinergic submandibular effects and muscarinic receptor expression in blood vessels of the rat","volume":"53","author":"Ryberg","year":"2008","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.bcp.2010.12.016_bib0115","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bcp.2007.07.014","article-title":"Identification of novel bradykinin-potentiating peptides (BPPs) in the venom gland of a rattlesnake allowed the evaluation of the structure\u2013function relationship of BPPs","volume":"74","author":"Gomes","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.12.016_bib0120","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1096\/fj.02-0363com","article-title":"Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo","volume":"16","author":"Feelisch","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2010.12.016_bib0125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0026-2862(73)90054-X","article-title":"An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy","volume":"5","author":"Baez","year":"1973","journal-title":"Microvasc Res"},{"key":"10.1016\/j.bcp.2010.12.016_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0041-0101(94)90020-5","article-title":"The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study","volume":"34","author":"Lomonte","year":"1994","journal-title":"Toxicon"},{"issue":"17","key":"10.1016\/j.bcp.2010.12.016_bib0135","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1074\/jbc.275.17.12900","article-title":"Selective regulation of endogenous G protein-coupled receptors by arrestins in HEK293 cells","volume":"275","author":"Mundell","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bcp.2010.12.016_bib0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2008.09.027","article-title":"Identification of functional bradykinin B(2) receptors endogenously expressed in HEK293 cells","volume":"77","author":"Kramarenko","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2010.12.016_bib0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cyto.a.20519","article-title":"Kinin-B2 receptor expression and activity during differentiation of embryonic rat neurospheres","volume":"73","author":"Martins","year":"2008","journal-title":"Cytometry A"},{"issue":"2","key":"10.1016\/j.bcp.2010.12.016_bib0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ceca.2007.04.007","article-title":"Mechanism of acetylcholine-induced calcium signaling during neuronal differentiation of P19 embryonal carcinoma cells in vitro","volume":"43","author":"Resende","year":"2008","journal-title":"Cell Calcium"},{"issue":"2","key":"10.1016\/j.bcp.2010.12.016_bib0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1742-1241.2008.01922.x","article-title":"Exercise blood pressure and endothelial dysfunction in hypertension","volume":"63","author":"Tzemos","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.bcp.2010.12.016_bib0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/BC.2001.007","article-title":"Kinins, receptors, kininases and inhibitors\u2014where did they lead us?","volume":"382","author":"Erd\u00f6s","year":"2001","journal-title":"Biol Chem"},{"issue":"7","key":"10.1016\/j.bcp.2010.12.016_bib0165","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.peptides.2005.03.046","article-title":"Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9alpha","volume":"26","author":"Mueller","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2010.12.016_bib0170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jjp.29.285","article-title":"Effects of chronic treatment with Captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats","volume":"29","author":"Antonaccio","year":"1979","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.bcp.2010.12.016_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/cs0580001","article-title":"Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat","volume":"58","author":"Marks","year":"1980","journal-title":"Clin Sci"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2010.12.016_bib0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1006854313163","article-title":"Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta","volume":"183","author":"Mittra","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bcp.2010.12.016_bib0185","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1023\/A:1007875100562","article-title":"Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat","volume":"14","author":"Houben","year":"2000","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.bcp.2010.12.016_bib0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/sita.200500061","article-title":"Hypothesized and found mechanisms for potentiation of bradykinin actions","volume":"6","author":"Mueller","year":"2006","journal-title":"Signal Transduct"},{"issue":"1","key":"10.1016\/j.bcp.2010.12.016_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cyto.a.20963","article-title":"The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist","volume":"79","author":"Negraes","year":"2011","journal-title":"Cytometry A"},{"key":"10.1016\/j.bcp.2010.12.016_bib0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2004.09.003","article-title":"Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline\u2013arginine regeneration pathway","volume":"69","author":"Shen","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.12.016_bib0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neuint.2003.07.007","article-title":"Kinin receptors in cultured rat microglia","volume":"45","author":"Noda","year":"2004","journal-title":"Neurochem Int"},{"issue":"5","key":"10.1016\/j.bcp.2010.12.016_bib0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/00005344-200111000-00016","article-title":"Endothelial adrenoceptors","volume":"38","author":"Vanhoutte","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.bcp.2010.12.016_bib0215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.pharmtox.44.101802.121622","article-title":"Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications","volume":"44","author":"Wess","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.bcp.2010.12.016_bib0220","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1152\/ajpheart.00430.2005","article-title":"Impaired cardiac and sympathetic autonomic control in rats differing in acetylcholine receptor sensitivity","volume":"289","author":"Padley","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.bcp.2010.12.016_bib0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10606820308263","article-title":"Cellular signaling mechanisms for muscarinic acetylcholine receptors","volume":"9","author":"Lanzafame","year":"2003","journal-title":"Receptors Channels"},{"issue":"5","key":"10.1016\/j.bcp.2010.12.016_bib0230","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1471-4159.2009.06092.x","article-title":"Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptors","volume":"109","author":"Servent","year":"2009","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.bcp.2010.12.016_bib0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-6147(00)01994-5","article-title":"The angiotensin-converting enzyme gene family: genomics and pharmacology","volume":"23","author":"Turner","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2010.12.016_bib0240","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-3565(24)29506-9","article-title":"Bradykinin B2 receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates","volume":"297","author":"Bachvarov","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.12.016_bib0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.toxicon.2007.11.003","article-title":"Tissue distribution in mice of BPP 10c, a potent proline-rich anti-hypertensive peptide of Bothrops jararaca","volume":"51","author":"Silva","year":"2008","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.bcp.2010.12.016_bib0250","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/01.RES.81.5.848","article-title":"Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells","volume":"81","author":"Minshall","year":"1997","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.bcp.2010.12.016_bib0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.coph.2009.10.009","article-title":"Functional crosstalk between GPCRs: with or without oligomerization","volume":"10","author":"Prezeau","year":"2010","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2010.12.016_bib0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0006-291X(03)01363-9","article-title":"Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE","volume":"308","author":"Fernandez","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.bcp.2010.12.016_bib0265","first-page":"554","article-title":"Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs","volume":"3","author":"Fernandez","year":"2004","journal-title":"Genet Mol Res"},{"issue":"3","key":"10.1016\/j.bcp.2010.12.016_bib0270","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/01.HYP.33.3.835","article-title":"Enhancement of bradykinin and resensitization of its B2 receptor","volume":"33","author":"Marcic","year":"1999","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2010.12.016_bib0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bcp.2010.12.016_bib0280","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/mol.109.056531","article-title":"A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning","volume":"76","author":"Sheffler","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2010.12.016_bib0285","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tips.2008.12.002","article-title":"Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.bcp.2010.12.016_bib0290","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets","volume":"117","author":"Langmead","year":"2008","journal-title":"Pharmacol Ther"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210008816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210008816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:13:37Z","timestamp":1740798817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210008816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0006295210008816"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.12.016","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}